Brief: Natera Q3 Revenue USD 592.2 Million Vs. IBES Estimate USD 512.5 Million
06/11/2025 21:05
Nov 06 (Reuters) - Natera Q3 income from operations USD -97.6 million. Q3 operating expenses USD 482 million Q3 net income USD -87.5 million outlook FY gross margin 62-64%
Recent news on Natera
See all newsBrief: FDA Grants Breakthrough Device Designation For Natera’S Multi-Cancer Early Detection Assay
Brief: Alliance Foundation Trials And Natera Announce Aft-70 Navigate A Global, Randomized, Phase Iii Trial Evaluating Genentech’S Oral Selective Estrogen Receptor Degrader With Signatera Mrd-Guided Cdk4/6 Inhibitor Therapy In Breast Cancer
US RESEARCH ROUNDUP-Chevron, Exxon Mobil, GoDaddy
Brief: Natera Says Signatera Commercial Launch In Japan Expected In 1H 2027
Brief: Natera To Support New Clinical Trial Assessing Ctdna Dynamics With Latitud In Advanced Skin Cancers